The most common cause of death for people with AD is aspiration pneumonia. This develops when a person does not swallow right. Food or liquid goes down the trachea (windpipe) instead of the esophagus (food pipe). This can cause blockage, damage, injury, and/or infection.
It also can cause chemical damage, known as chemical pneumonitis, which can result in inflammation because the lungs see the food as a foreign invader. It can also lead to pneumonia.
A number of factors determine the type of treatment: how early the pneumonia is caught, its severity, the amount of lung involved, the type(s) of bacteria included, and the person’s general health. In most cases, treatment options include support care, respiratory support, and antibiotics.
There are several ways to reduce the risk of aspiration. These include having the person eats with his or her head fully elevated and ensuring food is cut in small pieces for easy swallowing.
As discussed by the National Library of Medicine, other complications associated Alzheimer’s disease (AD) include:
Complications that arise from progressively degenerative symptoms of AD include:
- forgetting recent events or conversations
- difficulty performing more than one task at a time
- difficulty solving problems
- taking longer to perform hard activities
- language problems, such as trouble finding the name of familiar objects
- misplacing items
- getting lost on familiar routes
- personality changes and loss of social skills
- losing interest in activities previously enjoyed
- flat mood
- difficulty doing tasks that take some thought, but used to come easily, such as balancing a checkbook, playing complex games (such as bridge), and learning new information or routines
- forgetting details about current events
- forgetting events in their own life history and losing awareness of who they are
- change in sleep patterns like waking up at night
- difficulty reading or writing
- poor judgment and loss of ability to recognize danger
- using the wrong word, mispronouncing words, speaking in confusing sentences
- withdrawing from social contact
- having hallucinations, arguments, striking out, and violent behavior
- suffering from delusions, depression, and/or agitation
- difficulty doing basic tasks, such as preparing meals, choosing proper clothing, and driving
- difficulty swallowing both foods and liquids
If the AD reaches its final stages, the complications include a complete inability to:
- recognize family members
- understand language
- perform any of the basic activities of daily living, such as eating, dressing, going to the bathroom, and bathing
- Albert, M. S., Dekosky, S. T.,
Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The
diagnosis of mild cognitive impairment due to Alzheimer's disease:
Recommendations from the National Institute on Aging and Alzheimer's
Association workgroup. Alzheimers Dement.
- Alzheimer's Association. (2011). Press Release: New Criteria
and Guidelines for the Diagnosis of Alzheimer's Disease Published for the first
Time in 27 Years. The Alzheimer's
- Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A.,
& Bennett, D. A. (2004). Diabetes mellitus and risk of Alzheimer disease
and decline in cognitive function. Arch
Neurol, 61(5), 661-666.
- Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland,
D., & Jones, E. (2011). Alzheimer's disease. Lancet, 377(9770), 1019-1031.
- Bird, T. D. (2010). Early-Onset Familial Alzheimer Disease. University of Washington, Gene Review.
- Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for
cognitive impairment and dementia. Cochrane
Database Syst Rev(1), CD003120.
- Bosco, D., Fava, A., Plastino, M., Montalcini, T., &
Pujia, A. (2011). Possible implications of Insulin Resistance and Glucose
metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med.
- Boyle, P. A., Buchman, A. S., Barnes, L. L., & Bennett,
D. A. (2010). Effect of a purpose in life on risk of incident Alzheimer disease
and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry, 67(3), 304-310.
- Boyle, P. A., Buchman, A. S., Barnes, L. L., James, B. D.,
& Bennett, D. A. (2010). Association between life space and risk of
mortality in advanced age. J Am Geriatr
Soc, 58(10), 1925-1930.
- Brinkley, T. E., Lovato, J. F., Arnold, A. M., Furberg, C.
D., Kuller, L. H., Burke, G. L., et al. (2010). Effect of Ginkgo biloba on
blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens, 23(5), 528-533.
- Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E.,
Connolly, E. S., Cox, N. J., et al. (2010). NIH State-of-the-Science Conference
Statement: Preventing Alzheimer's Disease and Cognitive Decline. NIH Consens State Sci Statements, 27(4).
- De Felice, F. G., Vieira, M. N., Bomfim, T. R., Decker, H.,
Velasco, P. T., Lambert, M. P., et al. (2009). Protection of synapses against
Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of
Abeta oligomers. Proc Natl Acad Sci U S
A, 106(6), 1971-1976.
- deIpolyi, A. R., Rankin, K. P., Mucke, L., Miller, B. L.,
& Gorno-Tempini, M. L. (2007). Spatial cognition and the human navigation
network in AD and MCI. Neurology, 69(10),
- DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L.,
Kronmal, R. A., Ives, D. G., Saxton, J. A., et al. (2008). Ginkgo biloba for
prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253-2262.
- Fillit, H. M., Butler, R. N., O'Connell, A. W., Albert, M.
S., Birren, J. E., Cotman, C. W., et al. (2002). Achieving and maintaining
cognitive vitality with aging. Mayo Clin
Proc, 77(7), 681-696.
- Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish,
A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies
variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet, 41(10), 1088-1093.
- Herrmann, W., & Obeid, R. (2011). Homocysteine: a
biomarker in neurodegenerative diseases. Clin
Chem Lab Med, 49(3), 435-441.
- Keating, D. J., Chen, C., & Pritchard, M. A. (2006).
Alzheimer's disease and endocytic dysfunction: clues from the Down
syndrome-related proteins, DSCR1 and ITSN1. Ageing
Res Rev, 5(4), 388-401.
- Ladika, D. J., & Gurevitz, S. L. (2011). Identifying the
most common causes of reversible dementias: a review. JAAPA, 24(3), 28-31, 57.
- Li, K., Dai, D., Zhao, B., Yao, L., Yao, S., Wang, B., et al.
(2010). Association between the RAGE G82S polymorphism and Alzheimer's disease.
J Neural Transm, 117(1), 97-104.
- McKhanna, G. M., Knopmanc, D. S., Chertkowd, H., Hyman, B.
T., Clifford R. Jack, J., Kawash, C. H., et al. (2011). The diagnosis of
dementia due to Alzheimer’s disease: Recommendations from the National Institute
on Aging and the Alzheimer’s Association workgroup. Alzheimer’s & Dementia, 1–7.
- Nation, D. A., Hong, S., Jak, A. J., Delano-Wood, L., Mills,
P. J., Bondi, M. W., et al. (2011). Stress, exercise, and Alzheimer's disease:
A neurovascular pathway. Med Hypotheses.
- National Library of Medicine. (2011). Alzheimer's Disease. Medline Plus; U.S. National Library of
Medicine; National Institutes of Health.
- NCCAM. (2011). National Center for Complementary and
Alternative Medicine: The Ginkgo Evaluation of Memory (GEM) Study. National Institutes of Health' National
Center for Complementary and Alternative Medicine.
- NIA. (2008). Alzheimer's Disease: Unraveling the Mystery. National Institute on Aging; National Institutes of Heath; US
Department of Health and Human Services; NIH Publication Number 08-3782,
- NIA. (2011). Caring for a Person with Alzheimer's Disease;
Medicine Chart. National Institutes of
Health; National Institute on Aging; Alzheimer's Disease Education &
- NINDS. (2010). NINDS Alzheimer's Disease Information Page. National Institute of Neurological Disorders
and Stroke; National Institutes of Health; US Department of Health & Human
- NINDS. (2011). Dementia: Hope Through Research. National Institute of Neurological Disorders
and Stroke of the National Institutes of Health.
- Panza, F., Frisardi, V., Imbimbo, B. P., D'Onofrio, G.,
Pietrarossa, G., Seripa, D., et al. (2010). Bapineuzumab: anti-beta-amyloid
monoclonal antibodies for the treatment of Alzheimer's disease. Immunotherapy, 2(6), 767-782.
- Redish, A. D. (2001). The hippocampal debate: are we asking
the right questions? Behav Brain Res, 127(1-2),
- Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology
of Alzheimer disease. Nat Rev Neurol, 7(3),
- Reitz, C., den Heijer, T., van Duijn, C., Hofman, A., &
Breteler, M. M. (2007). Relation between smoking and risk of dementia and
Alzheimer disease: the Rotterdam Study. Neurology,
- Seneff, S., Wainwright, G., & Mascitelli, L. (2011).
Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate
diet. Eur J Intern Med, 22(2),
- Snitz, B. E., O'Meara, E. S., Carlson, M. C., Arnold, A. M.,
Ives, D. G., Rapp, S. R., et al. (2009). Ginkgo biloba for preventing cognitive
decline in older adults: a randomized trial. JAMA, 302(24), 2663-2670.
- Solomon, P. R., Adams, F., Silver, A., Zimmer, J., &
DeVeaux, R. (2002). Ginkgo for memory enhancement: a randomized controlled
trial. JAMA, 288(7), 835-840.
- Traykov, L., Rigaud, A. S., Cesaro, P., & Boller, F.
(2007). [Neuropsychological impairment in the early Alzheimer's disease]. Encephale, 33(3 Pt 1), 310-316.
- Uc, E. Y., Rizzo, M., Anderson, S. W., Shi, Q., & Dawson,
J. D. (2004). Driver route-following and safety errors in early Alzheimer
disease. Neurology, 63(5), 832-837.
- Wegiel, J., Gong, C. X., & Hwang, Y. W. (2011). The role
of DYRK1A in neurodegenerative diseases. FEBS
J, 278(2), 236-245.
- Wilson, R. S., Mendes De Leon, C. F., Barnes, L. L.,
Schneider, J. A., Bienias, J. L., Evans, D. A., et al. (2002). Participation in
cognitively stimulating activities and risk of incident Alzheimer disease. JAMA, 287(6), 742-748.
- Yu, F. (2011). Guiding Research and Practice: A Conceptual
Model for Aerobic Exercise Training in Alzheimer's Disease. Am J Alzheimers Dis Other Demen.